Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
China
Systematic reviews (SYSVAC)
All age groups
Clear all
Type of publications
Systematic reviews (SYSVAC)
(25)
Topics
Regions
Western Pacific
(25)
Countries
China
(25)
Australia
(2)
Brazil
(2)
Canada
(5)
Colombia
(1)
Ethiopia
(8)
France
(1)
Germany
(2)
India
(1)
Islamic Republic of Iran
(2)
Italy
(6)
Japan
(1)
Jordan
(1)
Malaysia
(1)
Pakistan
(2)
South Africa
(2)
Spain
(3)
United Kingdom
(2)
United States of America
(12)
Diseases
COVID-19
(14)
Haemophilus influenzae type B
(1)
Hepatitis A
(1)
Hepatitis B
(2)
Human papillomavirus (HPV)
(2)
Influenza
(2)
Mumps
(1)
Pneumococcal disease
(3)
Rabies
(1)
Rotavirus
(1)
Varicella
(1)
Publication date
2022
(3)
2021
(6)
2020
(11)
2018
(1)
2017
(1)
2014
(1)
2013
(1)
2012
(1)
Target population
All age groups
(25)
Adolescents
(10)
Adults
(16)
Children
(8)
Healthcare workers
(5)
Newborn
(4)
Older adults
(9)
Parents/caregivers
(6)
Pregnant women
(1)
Travellers
(1)
Available to download in languages
25 results found
2018
∙
Chen, K. Zhang, X. Shan, W. Zhao, G. Zhang, T.
Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China: A systematic review and meta-analysis
2017
∙
Wong, C. K. H. Liao, Q. Guo, V. Y. W. Xin, Y. Lam, C. L. K.
Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review
2014
∙
Wang, H. Hu, Y. Zhang, G. Zheng, J. Li, L. An, Z.
Meta-analysis of vaccine effectiveness of mumps-containing vaccine under different immunization srategies in China
2013
∙
Guo, B. A. Page, A. Wang, H. Q. Taylor, R. McIntyre, P.
Systematic review of reporting rates of adverse events following immunization: An international comparison of post-marketing surveillance programs with reference to China
2012
∙
Liu, Hui Ma, YongLei Wang, HongFei Liu, QiGui
Quantitative evaluation of the effect of the hepatitis B vaccine based on the HBsAg- and anti-HBs-positive rates in the Chinese population over the last 33 years
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register